Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
April 08, 2024 11:53 ET
|
Precision Neuroscience
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer. An expert in chip...
Precision Neuroscience Expands Clinical Research In Brain–Computer Interface
March 22, 2024 08:30 ET
|
Precision Neuroscience
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
February 29, 2024 01:41 ET
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
October 05, 2023 09:00 ET
|
Precision Neuroscience
NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced it has acquired a microelectromechanical systems...
ONWARD® kündigt die erste Implantation eines ARC-IM™-Stimulators mit Gehirn-Computer-Schnittstelle (BCI) beim Menschen an, um die Arm-, Hand- und Fingerfunktion nach einer Rückenmarksverletzung wiederherzustellen
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), das Medizintechnikunternehmen, das innovative Therapien zur Rückenmarkstimulation entwickelt, um Bewegung,...
ONWARD® annonce la première implantation chez l'homme du stimulateur ARC-IM™ avec interface cerveau-ordinateur pour restaurer les fonctions du bras, de la main et du doigt après une lésion médullaire.
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, 27 sept. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), l’entreprise de technologie médicale spécialisée dans la création de thérapies innovantes pour rétablir le...
ONWARD® kondigt aan dat ARC-IM™ stimulator met Brein-Computer Interface (BCI) voor het eerst bij mensen wordt geïmplanteerd om de functie van armen, handen en vingers na ruggenmergletsel te herstellen
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve ruggenmergstimulatietherapieën ontwikkelt om beweging, functie en...
ONWARD® Announces First-in-Human Implant of ARC-IM™ Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury
September 27, 2023 01:30 ET
|
ONWARD Medical NV
Eindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement,...
BCI Announces 3.5 Per Cent Annual Return for Fiscal 2023, Outperforming its Benchmark by 3.2 Per Cent
June 27, 2023 08:27 ET
|
BCI - British Columbia Investment Management Corp
Victoria, British Columbia, Canada, June 27, 2023 (GLOBE NEWSWIRE) -- Return highlights for the fiscal year ending March 31, 2023: One-year net annual return of 3.5%, representing $4.6...
Brain-Computer-Interface (BCI) ermöglicht durch Gedanken gesteuertes Gehen nach Rückenmarksverletzung
May 24, 2023 11:30 ET
|
ONWARD Medical
EINDHOVEN, Niederlande, May 24, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur Wiederherstellung von Bewegung,...